AESOP (Decision/Risk Analysis) Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 13

AESOP (Decision/Risk Analysis) General Information

Description

Developer of an artificial intelligence engine designed to detect prescription errors and improve clinical documentation accuracy. The company offers machine-learning-based decision support that flags prescriptions inconsistent with a patient's diagnosis, age, or gender and provides reporting tools for clinicians and medical coders, enabling healthcare users to enhance patient safety and medical billing accuracy.

Contact Information

Website
www.aesoptek.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2261 Market Street
  • Suite 4132
  • San Francisco, CA 94114
  • United States
+1 (339)
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Services
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 2261 Market Street
  • Suite 4132
  • San Francisco, CA 94114
  • United States
+1 (339)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AESOP (Decision/Risk Analysis) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Accelerator/Incubator 17-Jun-2025 Completed Generating Revenue
8. Accelerator/Incubator Completed Generating Revenue
7. Accelerator/Incubator 11-Aug-2022 Completed Generating Revenue
6. Early Stage VC (Series A) 31-Jul-2022 Completed Generating Revenue
5. Accelerator/Incubator 15-Sep-2020 Completed Generating Revenue
4. Seed Round 15-Mar-2020 Completed Generating Revenue
3. Accelerator/Incubator 01-Oct-2019 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. University Spin-Out 01-Jan-2019 Completed Startup
To view AESOP (Decision/Risk Analysis)’s complete valuation and funding history, request access »

AESOP (Decision/Risk Analysis) Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Pre-A2 Preferred
Pre-A1 Preferred
Pre-A Preferred 5,525,241 $0.000010 8% $0.53 $0.53 1x $0.53 25.46%
To view AESOP (Decision/Risk Analysis)’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

AESOP (Decision/Risk Analysis) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an artificial intelligence engine designed to detect prescription errors and improve clinical documentation
Decision/Risk Analysis
San Francisco, CA
18 As of 2023

Princeton, NJ
 

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AESOP (Decision/Risk Analysis) Competitors (15)

One of AESOP (Decision/Risk Analysis)’s 15 competitors is Noom, a Venture Capital-Backed company based in Princeton, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Noom Venture Capital-Backed Princeton, NJ
Hurdle (Decision/Risk Analysis) Venture Capital-Backed London, United Kingdom
Spring Health Venture Capital-Backed New York, NY
TAO Connect Formerly VC-backed Clearwater, FL
Omada Formerly VC-backed Dallas, TX
You’re viewing 5 of 15 competitors. Get the full list »

AESOP (Decision/Risk Analysis) Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

AESOP (Decision/Risk Analysis) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250078997-A1 Clinical recommendation method, clinical recommendation apparatus, and computer-readable recording medium Inactive 20-Feb-2023
WO-2024177618-A1 Clinical recommendation method, clinical recommendation apparatus, and computer-readable recording medium Inactive 20-Feb-2023
US-20220392649-A1 Clinical association evaluating apparatus and clinical association evaluating method Inactive 02-Jun-2021
US-20240153631-A1 Electronic device and method for providing recommended diagnosis Inactive 02-Jun-2021
WO-2022256027-A1 Electronic device and method for providing recommended diagnosis Inactive 02-Jun-2021 G16H50/70
To view AESOP (Decision/Risk Analysis)’s complete patent history, request access »

AESOP (Decision/Risk Analysis) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AESOP (Decision/Risk Analysis) Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
PharmStars Accelerator/Incubator
Mayo Clinic Platform Accelerator/Incubator Minority
500 Global Accelerator/Incubator Minority
BE Capital Corporation Minority
Colopl Next Corporate Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

AESOP (Decision/Risk Analysis) FAQs

  • When was AESOP (Decision/Risk Analysis) founded?

    AESOP (Decision/Risk Analysis) was founded in 2019.

  • Where is AESOP (Decision/Risk Analysis) headquartered?

    AESOP (Decision/Risk Analysis) is headquartered in San Francisco, CA.

  • What is the size of AESOP (Decision/Risk Analysis)?

    AESOP (Decision/Risk Analysis) has 18 total employees.

  • What industry is AESOP (Decision/Risk Analysis) in?

    AESOP (Decision/Risk Analysis)’s primary industry is Decision/Risk Analysis.

  • Is AESOP (Decision/Risk Analysis) a private or public company?

    AESOP (Decision/Risk Analysis) is a Private company.

  • What is AESOP (Decision/Risk Analysis)’s current revenue?

    The current revenue for AESOP (Decision/Risk Analysis) is .

  • How much funding has AESOP (Decision/Risk Analysis) raised over time?

    AESOP (Decision/Risk Analysis) has raised $3.86M.

  • Who are AESOP (Decision/Risk Analysis)’s investors?

    PharmStars, Mayo Clinic Platform, 500 Global, BE Capital, and Colopl Next are 5 of 13 investors who have invested in AESOP (Decision/Risk Analysis).

  • Who are AESOP (Decision/Risk Analysis)’s competitors?

    Noom, Hurdle (Decision/Risk Analysis), Spring Health, TAO Connect, and Omada are some of the 15 competitors of AESOP (Decision/Risk Analysis).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process